文献速递肿瘤 PET/CT甲状腺核医学

儿童神经母细胞瘤患者应用18F-FDG与18F-DOPA PET/CT容积参数进行风险分层

Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
PubMed 文献 · Clin Nucl Med · 2017-01-01

本研究纳入25例神经母细胞瘤患儿,于治疗前4周内行18F-FDG和18F-DOPA PET/CT,评估原发肿瘤容积参数(MTV、TLG、DTV、TLDA)的预后价值及其与临床、病理特征的相关性。中位随访28.2个月,仅容积参数在风险组间有显著差异,F-DOPA与F-FDG PET提供互补信息,均可用于风险分层。

要点

  • 非存活患儿(20%)18F-DOPA摄取的SUVDOPA、DTV、TLDA较低,而18F-FDG摄取的SUVFDG、MTV、TLG较高。
  • 较低的F-DOPA摄取与骨髓和淋巴结转移相关,较高的F-FDG摄取与MYCN扩增及解剖影像侵袭特征相关。
  • 仅容积参数(DTV、TLDA、MTV、TLG)在风险组间存在显著差异,与风险分组的关联更强。

核心结论

  • 治疗前18F-DOPA和18F-FDG PET提供互补信息,两者均可用于风险分层;容积参数与风险分组的关联更强。

研究设计与样本

  • 研究纳入25例神经母细胞瘤患儿,于治疗前4周内行18F-FDG和18F-DOPA PET/CT,记录原发肿瘤SUVmax及容积参数,按生存状态和临床特征分组比较,采用Kaplan-Meier法和log-rank检验比较生存曲线。

主要发现

  • 中位随访28.2个月,非存活患儿(20%)的SUVDOPA、DTV、TLDA较低(P ≤ 0.05),SUVFDG、MTV、TLG较高(均P < 0.05)。
  • 较低的F-DOPA摄取与骨髓和淋巴结转移相关(均P < 0.05)。
  • 较高的F-FDG摄取与MYCN扩增相关(均P < 0.05),并与肿瘤血管包绕或邻近器官侵犯等解剖侵袭特征相关(TLG,P = 0.05)。
  • 仅容积参数(DTV、TLDA、MTV、TLG)在风险组间存在显著差异(均P < 0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study determined the prognostic value of volumetric parameters derived from pretreatment F-FDG and F-DOPA PET/CT of neuroblastoma and their correlation with clinical and histopathologic features. PATIENTS AND METHODS: A total of 25 children with neuroblastoma underwent pretreatment F-FDG and F-DOPA PET/CT within 4 weeks. The SUVmax of primary tumors on F-FDG and F-DOPA PET were recorded as SUVFDG and SUVDOPA, respectively. For volumetric parameters of primary tumors, 40% of SUVmax was used to generate volume of interest. If the 40% of SUVmax was below 2.5, an SUV threshold of 2.5 was used instead. Metabolic tumor volume (MTV), total lesion glycolysis (TLG), dopaminergic tumor volume (DTV), and total lesion F-DOPA activity (TLDA) were recorded as F-FDG and F-DOPA volumetric parameters. All indices were compared between groups distinguished by survival status and clinical features, including bone marrow involvement, lymph node metastasis, amplification of the MYCN oncogene, invasive features on anatomic images, and risk categories. The Kaplan-Meier method and log-rank test were used to compare the survival curves between groups. RESULTS: The median follow-up period was 28.2 months. Nonsurvivors (20%) tended to have lower SUVDOPA, DTV, and TLDA (P ≤ 0.05), and higher SUVFDG, MTV, and TLG (all P < 0.05). Lower F-DOPA uptake is associated with bone marrow and lymph node metastases (all P < 0.05). Higher F-FDG uptake is associated with MYCN amplification (all P < 0.05) and anatomic invasive features of tumors such as vascular encasement or adjacent organ invasion (TLG, P = 0.05). Only volumetric indices (DTV, TLDA, MTV, and TLG) significantly differed among risk groups (all P < 0.05). CONCLUSIONS: Pretherapeutic F-DOPA and F-FDG PET provided complementary information, and both can be served for risk stratification. Volumetric indices of F-DOPA and F-FDG PET correlate more highly with risk grouping.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Liu CJ, Lu MY, Liu YL, et al. Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT. Clin Nucl Med. 2017. PMID: 28072621. doi:10.1097/RLU.0000000000001529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。